Compiled external resources with additional information on health and haemoglobin disorders-related issues.
‘Blood & Beyond’ is a multi-stakeholder initiative developed by Celgene, now part of Bristol Myers Squibb, involving experts from the fields of Haematology and Blood Management, Nursing, Patient Advocacy, and Health Economics.
The ‘Blood and Beyond Report’ proposes a shared vision for rethinking blood use in Europe to improve outcomes for patients. Drawing on the input of various experts, it contains policy recommendations to safeguard and optimise Europe’s blood supply; to reduce transfusion dependency and to facilitate innovation.
Read the full Blood & Beyond Report HERE
View the Blood & Beyond Infographic HERE
Read the Article ”Revisiting The Use & Management of Blood in Europe, in Times of Crisis & Beyond” HERE
Watch Androulla Eleftheriou´s Presentation on Blood & Beyond (2020 PanHellenic Congress on Economics & Health Policy) HERE (GR)
Watch Elena Mylona’s Video Interview on the Burden of Blood Transfusion HERE
The European Medicines Agency (EMA) has endorsed two statements for healthcare professionals and the general public about the importance, safety and effectiveness of vaccines published by the International Coalition of Medicines Regulatory Authorities (ICMRA).
International regulators from different countries and regions have come together and jointly developed these statements to reassure healthcare professionals and the public around the globe that medicines regulatory authorities only allow vaccines onto the market that fulfil the highest standards for safety, efficacy and quality.
In these statements, they also reiterate that it is everyone’s responsibility to get vaccinated in order to protect not only themselves but also their families, friends, communities, vulnerable populations who cannot get immunised as well as the generations to come.